| 000 | 01365 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516101228.0 | ||
| 264 | 0 | _c20121008 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchteingart, David E | |
| 245 | 0 | 0 |
_aStructural requirements for mitotane activity: development of analogs for treatment of adrenal cancer. _h[electronic resource] |
| 260 |
_bAnticancer research _cJul 2012 |
||
| 300 |
_a2711-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xchemistry |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 |
_aMitotane _xanalogs & derivatives |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aSinsheimer, Joseph E | |
| 700 | 1 | _aBenitez, Ricardo S | |
| 700 | 1 | _aHoman, Dominic F | |
| 700 | 1 | _aJohnson, Timothy D | |
| 700 | 1 | _aCounsell, Raymond E | |
| 773 | 0 |
_tAnticancer research _gvol. 32 _gno. 7 _gp. 2711-20 |
|
| 999 |
_c21912972 _d21912972 |
||